brbiotech.com (BNR): Wutah pendapatan triwulanan

Simbol lan logo merek Burning Rock Biotech Limited (BNR)

Burning Rock Biotech quarterly revenue growth reflects the business scaling dynamics, where the value -3.50 represents the current metric. Revenues are based on tumor genetic sequencing in China. However, geopolitics and government regulation create serious risks for profits. Meanwhile, Yusmao Yu's team is focusing on cost optimization to achieve break-even in the US and Asia.

Burning Rock Biotech Ltd. (BNR) - Wutah pendapatan triwulanan saka 04.07.2022 nganti 20.11.2026

Rincian metrik keuangan lan pasar Burning Rock (BNR)

- kuotasi saiki lan rata-rata prakiraan nilai:
- data dhuwit lan arus kas:
Analisis fundamental perusahaan:BNR - Burning Rock
Produk seri brbiotech.com

Professional managers utilize fundamental metrics to filter assets by evaluating the dynamics of capital inflow from core operations. This indicator measures the percentage change in quarterly revenue, reflecting the scaling rates of genetic testing system sales and the demand for tumor laboratory diagnostics at Burning Rock Biotech (BNR), which allows the real business expansion within the oncology market to be determined through the level of quarterly revenue growth.